NASDAQ
G1 Therapeutics, Inc. (GTHX) has a free cash flow growth of 40.73% as of Friday, May 29, 2026. This represents a 1051.90% increase compared to its 12-month average of -4.28%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.